Jessica Brehm

Jessica Brehm is a Director of Scientific Licensing at ViiV Healthcare since October 2017. Previously Jessica worked at GSK as a Manager of Business Development from December 2014 to September 2017 and at VGTI-FL as a Postdoctoral Associate from February 2012 to November 2014. With a PhD in Infectious Diseases and Microbiology from the University of Pittsburgh, Jessica has a background in HIV eradication research and has made significant contributions in identifying novel mechanisms of HIV latency and drug resistance mutations. Their strong communication skills and ability to lead matrix due diligence teams have been key in driving critical business decisions and implementing market research projects to inform business strategy in the field of therapeutics for HIV eradication.